CVS HEALTH CORPORATION - CVS STOCK NEWS

CVS Health will start administering COVID-19 vaccines to eligible residents on February 11 at 12 pharmacy locations in Connecticut. The rollout will include approximately 6,800 doses sourced from a federal partnership program. Appointments can be booked from February 9. The initiative is part of a broader plan involving 335 locations across 11 states with a capacity to administer 20-25 million shots monthly. CVS is also vaccinating residents at over 570 long-term care facilities in Connecticut, aiming to finish first doses by mid-February.

CVS Health will start offering COVID-19 vaccinations on February 11 at select locations across 11 states, initially providing approximately 250,000 doses sourced from the federal government. The company plans to expand its vaccination efforts as more supply becomes available. CVS aims to administer 20 to 25 million shots monthly, utilizing nearly 90,000 healthcare professionals. CVS has already begun vaccinations at long-term care facilities, aiming to complete first doses for over 40,000 facilities by mid-February.

CVS Health Corporation (NYSE:CVS) will host a conference call on February 16, 2021, at 8:00 a.m. ET to discuss its financial results for the fourth quarter of 2020. The call will be available via live audio webcast on CVS Health's Investor Relations website. The event aims to inform analysts and investors about the company's performance and strategic initiatives. CVS Health continues to enhance healthcare access and affordability through innovative services and community outreach that cater to the healthcare needs of nearly one in three Americans annually.

CVS Health Foundation has launched a $5 million Health Care Careers Scholarship program over five years, aimed at supporting Black and Latinx students pursuing health care degrees. This initiative is part of CVS's broader $600 million commitment to address racial inequities. Scholarships will target students in various health care-related fields and will be managed in collaboration with UNCF. Applications are open from February 1 to April 1, 2021, fostering a diverse pipeline of future health care professionals.

CVS Health has successfully administered the first round of COVID-19 vaccine doses to nearly 8,000 skilled nursing facilities across the U.S. With second doses already underway, CVS anticipates completion within four weeks. The rollout included more than 40,000 long-term care facilities, with first doses expected to be finished by mid-February. CVS can administer 20-25 million vaccine shots monthly, significantly impacting community vaccination efforts in partnership with federal programs.

CVS Health announces the appointment of Laurie Havanec as Executive Vice President and Chief People Officer, effective February 8, 2021. She succeeds Lisa Bisaccia, who is retiring after 16 years. Havanec brings over 20 years of HR experience, most recently from Otis Worldwide Co., and has previously held significant roles at United Technologies Corporation and Aetna. Havanec aims to enhance talent and culture initiatives, supporting CVS's strategy with a focus on engaging its workforce of 300,000 employees.

CVS Health (NYSE: CVS) has appointed Michelle Peluso as its first-ever Chief Customer Officer, effective January 25, 2021. This new executive role will focus on transforming the consumer experience and enhancing CVS's digital strategy. Peluso, who has over 25 years of experience, previously held senior positions at IBM and Citigroup, managing substantial revenue and improving customer engagement. Her addition aims to provide a personalized and seamless experience for customers within CVS Health's diverse healthcare offerings.

CVS Health is administering COVID-19 vaccines in skilled nursing facilities across 49 states, starting in 36 states and Washington, D.C. The first doses are expected to be completed by January 25. Approximately 8,000 out of 15,000 skilled nursing facilities have partnered with CVS. While the uptake among residents is high, initial staff vaccination rates are low, attributed to staggered visits. CVS plans to expand vaccine availability at retail locations based on state decisions. The company can administer 20-25 million shots per month.

CVS Health Corporation (NYSE: CVS) has declared a quarterly dividend of $0.50 per share on its common stock. This dividend will be payable on February 1, 2021, to shareholders of record as of January 22, 2021. CVS Health continues to enhance its health services, engaging nearly one in three Americans annually and focusing on improving healthcare accessibility and affordability through innovative services and community presence.